Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Sucampo Pharma Inc (SCMP)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 508,737
  • Shares Outstanding, K 46,460
  • Annual Sales, $ 230,060 K
  • Annual Income, $ 18,490 K
  • 36-Month Beta 1.46
  • Price/Sales 2.20
  • Price/Cash Flow 4.52
  • Price/Book 2.91

Price Performance

See More
Period Period Low Period High Performance
1-Month
10.32 +6.10%
on 06/22/17
11.20 -2.23%
on 07/14/17
+0.60 (+5.80%)
since 06/21/17
3-Month
9.40 +16.49%
on 06/16/17
11.20 -2.23%
on 07/14/17
+1.50 (+15.87%)
since 04/21/17
52-Week
9.30 +17.74%
on 04/18/17
17.55 -37.61%
on 11/30/16
-0.66 (-5.68%)
since 07/21/16

Most Recent Stories

More News
Dr. Karen Smith Joins Sucampo's Board of Directors

Sucampo Pharmaceuticals, Inc. (Sucampo) (NASDAQ:SCMP), a global biopharmaceutical company, today announced that Karen Smith, M.D., Ph.D., M.B.A., LLM., has joined the Company's Board of Directors on July...

SCMP : 10.95 (+0.46%)
Sucampo Pha-Cl A Down 21.4% Since SmarTrend Downtrend Call (SCMP)

SmarTrend identified a Downtrend for Sucampo Pha-Cl A (NASDAQ:SCMP) on December 20th, 2016 at $13.87. In approximately 7 months, Sucampo Pha-Cl A has returned 21.41% as of today's recent price of $10.90....

SCMP : 10.95 (+0.46%)
Top 5 Companies in the Pharmaceuticals Industry with the Best Relative Performance (OMER, SCMP, IPXL, CTLT, SUPN)

We looked at the Pharmaceuticals industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We look...

SCMP : 10.95 (+0.46%)
CTLT : 35.79 (-0.17%)
SUPN : 42.20 (-0.24%)
IPXL : 18.15 (+1.11%)
OMER : 21.96 (+0.55%)
Sucampo (SCMP) Remains Focused on Amitza Label Expansion

We issued an updated report on Sucampo Pharmaceuticals, Inc. (SCMP) on July 4.

ENZ : 11.35 (-1.05%)
MYL : 39.17 (-0.81%)
SCMP : 10.95 (+0.46%)
SNY : 47.71 (-0.73%)
29.3% Return Seen to Date on SmarTrend Sucampo Pharmaceuticals Call (SCMP)

SmarTrend identified a Downtrend for Sucampo Pharmaceuticals (NASDAQ:SCMP) on December 20th, 2016 at $13.87. In approximately 6 months, Sucampo Pharmaceuticals has returned 29.34% as of today's recent...

SCMP : 10.95 (+0.46%)
Sucampo Pharmaceuticals Shares Down 27.9% Since SmarTrend's Sell Call (SCMP)

SmarTrend identified a Downtrend for Sucampo Pharmaceuticals (NASDAQ:SCMP) on December 20th, 2016 at $13.87. In approximately 6 months, Sucampo Pharmaceuticals has returned 27.90% as of today's recent...

SCMP : 10.95 (+0.46%)
Why Is Sucampo (SCMP) Up 1.5% Since the Last Earnings Report?

Sucampo (SCMP) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

SCMP : 10.95 (+0.46%)
Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the Jefferies 2017 Global Healthcare Conference

Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that it will webcast its corporate presentation at the Jefferies 2017 Global Healthcare Conference...

SCMP : 10.95 (+0.46%)
Sucampo Pharmaceuticals Shares Down 21.8% Since SmarTrend's Sell Call (SCMP)

SmarTrend identified a Downtrend for Sucampo Pharmaceuticals (NASDAQ:SCMP) on December 20th, 2016 at $13.87. In approximately 5 months, Sucampo Pharmaceuticals has returned 21.77% as of today's recent...

SCMP : 10.95 (+0.46%)
Sucampo Pharmaceuticals Has Returned 26.8% Since SmarTrend Recommendation (SCMP)

SmarTrend identified a Downtrend for Sucampo Pharmaceuticals (NASDAQ:SCMP) on December 20th, 2016 at $13.87. In approximately 5 months, Sucampo Pharmaceuticals has returned 26.82% as of today's recent...

SCMP : 10.95 (+0.46%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 48% Buy with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators mostly agree with the trend.

See More

Business Summary

Sucampo Pharmaceuticals, Inc. is an emerging pharmaceutical company focused on the discovery, development and commercialization of proprietary drugs based on prostones, a class of compounds derived from functional fatty acids that occur naturally in the human body. Sucampo is focused on developing prostones...

See More

Support & Resistance

2nd Resistance Point 11.08
1st Resistance Point 11.02
Last Price 10.95
1st Support Level 10.87
2nd Support Level 10.78

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.